Streetbeat News

Revenues

IDYA

In the past three months, IDEAYA Biosciences (NASDAQ:IDYA) received varied analyst ratings, shifting from bullish to somewhat bullish with no bearish or indifferent ratings. The average 12-month price target for IDYA has risen 24.02% to $55.4, reflecting a positive outlook from analysts. The company, focused on precision medicine in oncology, shows a challenging revenue growth with a -2.49% decline over 3 months but maintains a strong net margin and ROE, despite a below-average ROA and a conservative debt management approach.

Portfolio Pulse from Benzinga Insights

May 08, 2024 | 5:01 pm

AVNT

Avient (NYSE:AVNT) has received mixed analyst ratings over the last three months, with a recent shift towards more bullish perspectives. The average 12-month price target for AVNT has been raised to $51.00, indicating a positive outlook from financial experts. Analysts from Wells Fargo, Stifel, and Oppenheimer have raised their price targets, reflecting optimism about the company's performance. Despite facing a revenue decline of -9.03% over the past 3 months, Avient's net margin outperforms industry standards, showcasing strong profitability. However, challenges in ROE and ROA suggest areas for improvement.

Portfolio Pulse from Benzinga Insights

May 08, 2024 | 5:01 pm

YOU

Clear Secure (NYSE:YOU) has received mixed analyst evaluations over the last three months, with ratings ranging from bullish to bearish. The average 12-month price target for YOU has increased by 16.18% to $33.11. Analysts' actions include maintaining, raising, and lowering ratings and price targets, reflecting their response to market dynamics and company performance. Clear Secure's financial performance shows a solid revenue growth rate of 33.3%, an exceptional net margin of 8.17%, and strong ROE and ROA, indicating efficient management and financial health.

Portfolio Pulse from Benzinga Insights

May 08, 2024 | 5:00 pm

PINC

In the past three months, Premier (NASDAQ:PINC) received neutral ratings from four analysts, with a negative shift in sentiment and a 13.62% decrease in the average price target to $21.88. Analysts from Piper Sandler, Canaccord Genuity, Baird, and Leerink Partners have lowered their price targets, reflecting concerns over Premier's market performance and financial health. Despite challenges in revenue growth and market capitalization, Premier maintains strong profitability indicators such as net margin, ROE, and ROA, and a low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

May 08, 2024 | 5:00 pm

AAPL

NVDA

VGT

XLK

Apple Inc (NASDAQ:AAPL) has seen a 12% increase in iPhone shipments in China for March, following price cuts by the company and its Chinese retailers. This growth comes after a significant sales decline, with Apple facing competition from local brands and geopolitical challenges, including a U.S. chip ban affecting companies like Nvidia Corp (NASDAQ:NVDA). Despite these obstacles, Apple's strategic pricing adjustments have led to a rebound in its Chinese market share. Additionally, Apple's stock and exposure through ETFs like Vanguard Information Tech ETF (NYSE:VGT) and SPDR Select Sector Fund - Technology (NYSE:XLK) are highlighted, with AAPL shares experiencing a slight decrease in recent trading.

Portfolio Pulse from Anusuya Lahiri

May 08, 2024 | 4:55 pm

WBD

Warner Bros. Discovery is planning new cost-cutting measures and an increase in the price of its Max streaming service, according to Bloomberg. This move is part of the company's ongoing efforts to streamline operations and improve profitability.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 4:26 pm

SGD

Safe & Green (SGD) reported a decrease in FY23 revenue to $16.5M from $24.4M year-over-year, indicating a significant drop in sales.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 4:14 pm

CRCT

DV

INOD

INSP

REBN

TMCI

U.S. stocks showed mixed performance with the Dow Jones gaining, while the NASDAQ and S&P 500 fell. Crude oil inventories decreased, impacting oil prices positively. Reborn Coffee, Cricut, and Innodata shares surged following positive financial news, whereas Treace Medical Concepts, DoubleVerify Holdings, and Inspire Medical Systems saw significant drops after disappointing financial results.

Portfolio Pulse from Avi Kapoor

May 08, 2024 | 4:10 pm

RWAY

Analysts have recently adjusted their ratings and price targets for Runway Growth Finance Corp (NASDAQ:RWAY), indicating a negative shift in sentiment. The average 12-month price target was lowered by 7.55% to $12.85, with a high estimate of $13.50 and a low of $12.00. This adjustment follows a period where analysts' sentiments shifted from bullish to more indifferent, with the total ratings now including 2 bullish and 3 indifferent positions. The company faces significant financial challenges, including a dramatic revenue decline of -90.98% as of December 31, 2023, a net margin of -229.17%, and below-average returns on equity and assets.

Portfolio Pulse from Benzinga Insights

May 08, 2024 | 4:01 pm

ICHR

Seven analysts have recently updated their ratings on Ichor Holdings (NASDAQ:ICHR), showing a mix of bullish and indifferent stances. The average 12-month price target is now $46.00, up 7.6% from the previous $42.75, with individual targets ranging from $40.00 to $55.00. Despite the positive analyst sentiment, Ichor Holdings faces financial challenges, including a significant revenue decline of -32.56% over the past three months, a net margin of -5.85%, and a high debt-to-equity ratio of 0.51.

Portfolio Pulse from Benzinga Insights

May 08, 2024 | 4:00 pm